News

Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model

Scorpius announces the launch of Scorpius Ventures, a new business unit designed to support emerging biotech companies with a flexible American onshoring model.

November 19, 2024

Scorpius Holdings Selected to Join Medical CBRN Defense Consortium

Scorpius announces that it has been selected to join Medical CBRN Defense Consortium to advance medical countermeasures against chemical, biological, radiological, and nuclear threats.

October 3, 2024

Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-Consortium

Scorpius announces that it has been accepted into the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), a part of the National Biopharmaceutical Manufacturing Partnership.

September 10, 2024

Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA

Scorpius announces that it has been selected as a member of the Biomedical Advanced Research and Development Authority’s (BARDA) Rapid Response Partnership Vehicle (RRPV).

September 10, 2024

NightHawk Biosciences Completes Name Change to Scorpius Holdings

NightHawk Biosciences announced its name change to Scorpius Holdings, Inc., to better reflect the company’s successful shift into a pure-play, large molecule biomanufacturing CDMO.

February 6, 2024

Scorpius BioManufacturing Announces Joe Payne as President and Chief Operating Officer

Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), promoted Joe Payne to President and COO.

February 1, 2024

Scorpius Expands Leadership Team With New VP, Manufacturing Operations

Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), expanded its leadership to include Matthew R. LeClair.